{"id":"https://openalex.org/W7223159307","doi":"https://doi.org/10.1016/j.htct.2026.107477","title":"ALTERNATIVE SPLICING DYNAMICS IN CML","display_name":"ALTERNATIVE SPLICING DYNAMICS IN CML","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223159307","doi":"https://doi.org/10.1016/j.htct.2026.107477"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107477","doi":"https://doi.org/10.1016/j.htct.2026.107477","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107477","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926012241/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S2531137926012241/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111331319","display_name":"Marianne Camile Silva de Sousa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marianne Camile Silva SOUSA","raw_affiliation_strings":["Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007047110","display_name":"Gustavo Trevizani Stelzer","orcid":"https://orcid.org/0000-0002-3605-4874","observed_orcids":["https://orcid.org/0000-0002-3605-4874"]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gustavo Trevizani STELZER","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093086548","display_name":"Daniel Blajberg Schaffel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Daniel Blajberg SCHAFFEL","raw_affiliation_strings":["Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159189298","display_name":"Leandro FARIAS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Leandro FARIAS","raw_affiliation_strings":["Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159173208","display_name":"Laura Zalcberg RENAULT","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Laura Zalcberg RENAULT","raw_affiliation_strings":["Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I122140584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005854956","display_name":"Telma Fran\u00e7a Padilha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Telma Fran\u00e7a PADILHA","raw_affiliation_strings":["Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152762004","display_name":"Ilana Zalcberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ilana ZALCBERG","raw_affiliation_strings":["Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159194135","display_name":"Bruna Souza Sabioni GON\u00c7ALVES","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]},{"id":"https://openalex.org/I4210138087","display_name":"Hospital Universit\u00e1rio Clementino Fraga Filho","ror":"https://ror.org/04pznag94","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210138087"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Bruna Souza Sabioni GON\u00c7ALVES","raw_affiliation_strings":["Departamento de Hematologia, Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Hematologia, Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I122140584","https://openalex.org/I4210138087"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004066980","display_name":"Luciana M. Gutiyama","orcid":"https://orcid.org/0000-0002-1644-8120","observed_orcids":["https://orcid.org/0000-0002-1644-8120"]},"institutions":[{"id":"https://openalex.org/I4210142683","display_name":"Instituto Nacional de C\u00e2ncer - INCA","ror":"https://ror.org/055n68305","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210142683"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Luciana Mayumi GUTIYAMA","raw_affiliation_strings":["Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de C\u00e2ncer, Rio de Janeiro, RJ, Brazil","institution_ids":["https://openalex.org/I4210142683"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80495785,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107477","last_page":"107477"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.5145999789237976,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.3781999945640564,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alternative-splicing","display_name":"alternative splicing","score":0.8510000109672546},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.8069999814033508},{"id":"https://openalex.org/keywords/exon-7-skipping","display_name":"exon 7 skipping","score":0.8220000267028809},{"id":"https://openalex.org/keywords/splice-variants","display_name":"splice variants","score":0.8180000185966492},{"id":"https://openalex.org/keywords/ezh2","display_name":"EZH2","score":0.949999988079071},{"id":"https://openalex.org/keywords/celf2","display_name":"CELF2","score":0.9959999918937683},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9950000047683716},{"id":"https://openalex.org/keywords/splicing-regulators","display_name":"splicing regulators","score":0.781000018119812},{"id":"https://openalex.org/keywords/leukemic-burden","display_name":"leukemic burden","score":0.6380000114440918},{"id":"https://openalex.org/keywords/blast-crisis","display_name":"blast crisis","score":0.7319999933242798},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6890000104904175},{"id":"https://openalex.org/keywords/longitudinal-follow-up","display_name":"longitudinal follow-up","score":0.3569999933242798},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.3479999899864197},{"id":"https://openalex.org/keywords/bcr-abl1-transcript-levels","display_name":"BCR-ABL1 transcript levels","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C40000846","wikidata":"https://www.wikidata.org/wiki/Q915868","display_name":"Spliceosome","level":5,"score":0.8652999997138977},{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.8065000176429749},{"id":"https://openalex.org/C194583182","wikidata":"https://www.wikidata.org/wiki/Q21114084","display_name":"Alternative splicing","level":4,"score":0.633400022983551},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.593500018119812},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5303000211715698},{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.5238999724388123},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.48820000886917114},{"id":"https://openalex.org/C94671646","wikidata":"https://www.wikidata.org/wiki/Q207551","display_name":"Intron","level":3,"score":0.486299991607666},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.45170000195503235},{"id":"https://openalex.org/C2778776201","wikidata":"https://www.wikidata.org/wiki/Q3474283","display_name":"Exon skipping","level":5,"score":0.4352000057697296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4239000082015991},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.41760000586509705},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41589999198913574},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.41100001335144043},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3878999948501587},{"id":"https://openalex.org/C42576000","wikidata":"https://www.wikidata.org/wiki/Q5420618","display_name":"Exonic splicing enhancer","level":5,"score":0.38449999690055847},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.3425000011920929},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3084999918937683},{"id":"https://openalex.org/C2778274637","wikidata":"https://www.wikidata.org/wiki/Q5510282","display_name":"Fusion transcript","level":4,"score":0.3037000000476837},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2930999994277954},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.28299999237060547},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2824000120162964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2806999981403351},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.27559998631477356},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2736999988555908}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107477","doi":"https://doi.org/10.1016/j.htct.2026.107477","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107477","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926012241/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:0241eb35a38548b6a96dc7e2e1c9b1b5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0241eb35a38548b6a96dc7e2e1c9b1b5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107477- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107477","doi":"https://doi.org/10.1016/j.htct.2026.107477","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107477","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926012241/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223159307.pdf","grobid_xml":"https://content.openalex.org/works/W7223159307.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3020964254","https://openalex.org/W2559871165","https://openalex.org/W4297348320","https://openalex.org/W2013696443","https://openalex.org/W2031237524","https://openalex.org/W4403568907","https://openalex.org/W6989196996","https://openalex.org/W2342914106","https://openalex.org/W2504575687","https://openalex.org/W1967696458"],"abstract_inverted_index":{"Alternative":[0],"splicing":[1,19,68,107,135,255,282,368,394,472,481],"has":[2,31],"emerged":[3],"as":[4,214,216,299,432,466,482],"a":[5,76,280,317,467,483],"key":[6],"mechanism":[7],"contributing":[8],"to":[9,95,137,245,254,405],"cancer":[10],"biology.":[11,488],"In":[12,147,258,325,443],"Chronic":[13],"Myeloid":[14],"Leukemia":[15],"(CML),":[16],"dysregulation":[17],"of":[18,85,97,113,154,205,234,320,423,471,479,486],"regulators,":[20],"including":[21,70,198],"U2AF1,":[22,429],"HNRNPA1,":[23],"CELF2,":[24,236],"MYC":[25,238,445],"and":[26,63,75,92,159,166,172,180,196,201,237,243,247,306,349,411,430,446,457,475],"the":[27,53,131,152,424,433],"epigenetic":[28],"regulator":[29],"EZH2,":[30,235,428],"been":[32,81],"reported.":[33],"The":[34,222,271],"spliceosome":[35],"pathway":[36],"is":[37,49],"also":[38,269],"enriched":[39,382],"in":[40,43,65,83,93,116,164,169,189,250,262,375,383,393,403,438],"CML,":[41],"especially":[42],"blast":[44],"crisis":[45],"patients.":[46],"Although":[47,366],"CML":[48,86,117,138,170,191,409,439,455,474,487],"primarily":[50],"driven":[51],"by":[52,88,99,184,241,279,301],"BCR::ABL1":[54,127,176,408],"fusion":[55],"gene,":[56],"increasing":[57],"evidence":[58],"indicates":[59],"supplementary":[60],"co-mutational":[61],"patterns":[62],"abnormalities":[64],"splicing.":[66],"Recurrent":[67],"variants,":[69],"exon":[71],"7":[72],"skipping":[73],"(\u03947)":[74],"35-bp":[77],"insertion":[78],"(INS35),":[79],"have":[80],"detected":[82,355,371],"25\u201330%":[84],"cases":[87,98],"Sanger":[89],"sequencing":[90],"(SS)":[91],"up":[94],"70%":[96],"next-generation":[100],"sequencing.":[101],"These":[102],"findings":[103,121,463],"suggest":[104],"that":[105,133,339],"alternative":[106],"may":[108],"provide":[109],"an":[110,143],"additional":[111],"layer":[112],"molecular":[114,312,334,469],"regulation":[115],"pathogenesis.":[118],"Our":[119],"previous":[120],"associated":[122,161],"these":[123,462],"variants":[124,256,340,369,379],"with":[125,162,175,226,284,296,331,345],"higher":[126,351],"transcript":[128,177],"levels,":[129],"supporting":[130],"hypothesis":[132],"aberrant":[134,480],"contributes":[136],"biology":[139],"rather":[140,358],"than":[141,359],"being":[142],"isolated":[144],"transcriptional":[145],"event.":[146],"this":[148],"study,":[149],"we":[150],"investigated":[151],"expression":[153,233,287,392,419,452],"splicing-related":[155,260],"genes":[156,261,437],"(EZH2,":[157],"CELF2":[158,414,447],"MYC)":[160],"changes":[163],"\u03947":[165,179,292,352],"INS35":[167,181,327],"frequencies":[168,374],"samples":[171,192,210,218,251,396,440],"their":[173],"correlation":[174],"levels.":[178],"were":[182,208,354,370,380],"evaluated":[183],"SS":[185],"or":[186,333],"fragment":[187],"analysis":[188,272,288,422],"882":[190],"collected":[193],"between":[194,454],"2020":[195],"2026,":[197],"263":[199],"diagnostic":[200],"639":[202],"follow-up":[203,344],"samples,":[204],"which":[206],"267":[207],"longitudinal":[209],"from":[211,219],"31":[212],"patients,":[213],"well":[215],"53":[217],"healthy":[220,376,458],"donors.":[221,442],"study":[223],"was":[224,239,268],"conducted":[225],"Ethics":[227],"Committee":[228],"approval":[229],"(CAAE:":[230],"96613326.3.0000.5274).":[231],"Relative":[232],"quantified":[240],"RT-qPCR":[242],"normalized":[244],"HPRT1":[246],"GAPDH":[248],"(GeNorm)":[249],"arranged":[252],"according":[253],"identification.":[257],"parallel,":[259],"public":[263],"RNA-seq":[264,421],"data":[265],"(GSE100026;":[266],"GSE144119)":[267],"analyzed.":[270],"proceeds":[273],"using":[274,290,316],"STAR":[275],"for":[276],"alignment,":[277],"followed":[278],"dedicated":[281],"filter":[283],"rMATS.":[285],"Differential":[286],"proceeded":[289],"Limma.":[291],"VAF":[293,318],"positively":[294],"correlated":[295],"leukemic":[297],"burden,":[298],"measured":[300],"%BCR::ABL1IS":[302,332],"(p":[303,322],"=":[304,323],"0.03),":[305],"significantly":[307,350,381],"discriminated":[308],"patients":[309,410,456],"achieving":[310],"deep":[311],"response":[313],"(MR":[314],"4.0-4.5)":[315],"cut-off":[319],"16.88%":[321],"0.009).":[324],"contrast,":[326,444],"showed":[328,389,415],"no":[329,346,416,449],"association":[330],"response.":[335],"Longitudinal":[336],"analyses":[337,388],"demonstrated":[338],"fluctuate":[341],"across":[342],"patients'":[343],"prognostic":[347],"value;":[348],"VAFs":[353],"at":[356,360,372],"diagnosis":[357],"relapse":[361],"(11%":[362],"vs.":[363,399],"6%;":[364],"p=0.02).":[365],"both":[367,378],"lower":[373],"donors,":[377,412],"BCR::ABL1-positive":[384],"samples.":[385,460],"Preliminary":[386],"qPCR":[387],"increased":[390],"EZH2":[391,465],"variant-positive":[395,473],"(log2FC":[397],"+3.7/+3.0":[398],"controls;":[400],"HPRT/GAPDH":[401],"normalized)":[402],"comparison":[404],"either":[406],"wild-type":[407],"whereas":[413],"significant":[417,450],"gene":[418,451],"alteration.":[420],"GSE100026":[425],"dataset":[426],"identified":[427],"PRPF8":[431],"most":[434],"differentially":[435],"expressed":[436],"vs":[441],"exhibited":[448],"alteration":[453],"control":[459],"Overall,":[461],"identify":[464],"candidate":[468],"correlate":[470],"support":[476],"further":[477],"investigation":[478],"novel":[484],"aspect":[485]},"counts_by_year":[],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2026-10-22T00:00:00"}